pyrrolidonecarboxylic acid has been researched along with Cardiovascular Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berezikov, E; Bischoff, R; de Boer, RA; Domian, IJ; Gil, A; Hoes, M; Ovchinnikova, ES; Silljé, HHW; Tromp, J; van de Sluis, B; van der Harst, P; van der Meer, P; van der Pol, A; van Deursen, JM; van Gilst, WH; van Veldhuisen, DJ; Voors, AA; Vreeswijk-Baudoin, I | 1 |
| Bischoff, R; Gil, A; van der Meer, P; van der Pol, A | 1 |
2 other study(ies) available for pyrrolidonecarboxylic acid and Cardiovascular Stroke
| Article | Year |
|---|---|
Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH.
Topics: Animals; Cardiotonic Agents; ERRalpha Estrogen-Related Receptor; Fetus; Heart Failure; Heart Function Tests; Humans; Mice, Transgenic; Myocardial Infarction; Myocardium; Oxidative Stress; Pyroglutamate Hydrolase; Pyrrolidonecarboxylic Acid; Rats; Receptors, Estrogen; Reperfusion Injury; Sequence Analysis, RNA; Stress, Mechanical; Transcription, Genetic | 2017 |
LC-MS analysis of key components of the glutathione cycle in tissues and body fluids from mice with myocardial infarction.
Topics: Animals; Chromatography, Liquid; Coronary Vessels; Glutamic Acid; Glutathione; Kidney; Ligation; Liver; Mice; Myocardial Infarction; Myocardium; Oxidation-Reduction; Pyrrolidonecarboxylic Acid; Tandem Mass Spectrometry | 2018 |